The IASLC mesothelioma staging project: improving staging of a rare disease through international participation

Harvey Pass, Dorothy Giroux, Catherine Kennedy, Enrico Ruffini, Ayten K Cangir, David Rice, Hisao Asamura, David Waller, John Edwards, Walter Weder, Hans Hoffmann, Jan P Van Meerbeeck, Anna Nowak, Valerie W Rusch, Peter Goldstraw, Ramón Rami-Porta, David Ball, David Beer, Ricardo Beyruti, Vanessa Bolejack, Kari Chansky, John Crowley, Frank Detterbeck, Wilfried Ernst Erich Eberhardt, Françoise Galateau-Sallé, Fergus Gleeson, Patti Groome, James Huang, Jhingook Kim, Young Tae Kim, Laura Kingsbury, Haruhiko Kondo, Mark Krasnik, Kaoru Kubota, Antoon Lerut, Gustavo Lyons, Mirella Marino, Edith M Marom, Jan van Meerbeeck, Alan Mitchell, Takashi Nakano, Andrew G Nicholson, Michael Peake, Thomas Rice, Kenneth Rosenzweig, Valerie Rusch, Nagahiro Saijo, Paul Van Schil, Jean-Paul Sculier, Lynn Shemanski, Kelly Stratton, Kenji Suzuki, Yuji Tachimori, Charles F Thomas Jr, William Travis, Ming S Tsao, Andrew Turrisi, Johan Vansteenkiste, Hirokazu Watanabe, Yi-Long Wu, Paul Baas, Jeremy Erasmus, Seiki Hasegawa, Kouki Inai, Kemp Kernstine, Hedy Kindler, Lee Krug, Kristiaan Nackaerts, Conrad Falkson, Pier Luigi Filosso, Giuseppe Giaccone, Kazuya Kondo, Marco Lucchi, Meinoshin Okumura, Eugene Blackstone, H Asamura, H Batirel, A Bille, U Pastorino, S Call, A Cangir, S Cedres, J Friedberg, F Galateau-Salle, K Kernstine, H Kindler, B McCaughan, T Nakano, A Nowak, C Atinkaya Ozturk, H Pass, M de Perrot, F Rea, D Rice, R Rintoul, E Ruffini, V Rusch, L Spaggiari, D Galetta, K Syrigos, C Thomas, J van Meerbeeck, J Vansteenkiste, W Weder, I Opitz, M Yoshimura

2016-12-01

Abstract:For nearly 40 years, there was no generally accepted staging system for malignant pleural mesothelioma. In 1994, members of the International Mesothelioma Interest Group, in collaboration with the International Association for the Study of Lung Cancer, proposed a TNM staging system based on analyses of outcomes in retrospective surgical series and small clinical trials. Subsequently accepted by the American Joint Commission on Cancer and the Union for International Cancer Control for the sixth editions of their staging manuals, this system has since been the international staging standard. However, it has significant limitations, particularly with respect to clinical staging and to the categories for lymph node staging. Here we provide an overview of the development of the International Association for the Study of Lung Cancer malignant pleural mesothelioma staging database, which was designed to address …